Marc Zienkiewicz chats with Nathalie Charland, senior director of scientific and medical affairs for the Quebec-based Medicago, about the company’s new COVID-19 vaccine candidate made using a plant-based technology platform.
Marc Zienkiewicz chats with Nathalie Charland, senior director of scientific and medical affairs for the Quebec-based Medicago, about the company’s new COVID-19 vaccine candidate made using a plant-based technology platform.